Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sequential Chemotherapy Prior Conditioning Reduced Intensity: Study Routine Care in Haploidentical Allogeneic Hematopoietic Stem Cells in Patients With Relapsed or Refractory Lymphoid Hematological Disorders

NCT03079089 is registered in ClinicalTrials.gov with Association for Training, Education, and Research in Hematology, Immunology, and Transplantation as lead sponsor.

NCT NCT03079089
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03079089 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sequential Chemotherapy Prior Conditioning Reduced Intensity: Study Routine Care in Haploidentical Allogeneic Hematopoietic Stem Cells in Patients With Relapsed or Refractory Lymphoid Hematological Disorders
Lead sponsor
Association for Training, Education, and Research in Hematology, Immunology, and Transplantation
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2017
Completion date
September 11, 2023
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

refractory or relapsed lymphoid haemopathy